Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.01 USD | +0.25% | -0.50% | -41.67% |
May. 06 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
Apr. 16 | SAB Biotherapeutics, Inc. Provides SAB-142 Trial Update | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 4.400 | 6.000 | 6.400 |
Spread/Res. | -8.86% | -33.17% | -37.34% |
Spread/Supp. | +1.78% | +1.78% | +28.53% |
Support | 3.940 | 3.940 | 3.120 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- SABS Stock
- Charts SAB Biotherapeutics, Inc.